Accepted at 8:33 a.m. Dec, 21, 2024 by Ahmed7
Author: ronin16319
Co-authors: Ahmed7
Related Note: 1484950422509
Rationale for change

Mnemonic from FA 2024 p567

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#AMBOSS::vaaAmQ #AK_Step2_v12::#UWorld::Step::105921 #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::03_Opioids #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::01_Anesthetics_&_Analgesics::03_Opiates,_Naloxone,_Naltrexone #AK_Step1_v12::#UWorld::Step::16502 #AK_Step2_v12::!Shelf::EM #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::03_Specific_toxicity_treatments #AK_Step1_v12::#UWorld::Step::1256 #AK_Step1_v12::#Bootcamp::Pharmacology::01_Pharmacodynamics::09_Drug-Receptor_Interactions #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::21_Opioid_Clinical_Use,_Mechanism_and_Overdose #AK_Step1_v12::#Bootcamp::Pharmacology::04_Side_Effects_and_Toxins::02_Pharmacological_Toxicity_and_Treatment #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention #AK_Step2_v12::#UWorld::Step::6889 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step2_v12::#UWorld::COMLEX::106686 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#UWorld::COMLEX::102301 #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::30_Opioid_Withdrawal,_Detoxification_and_Relapse_Prevention #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step2_v12::#B&B::13_Psych::03_Substance_Abuse::02_Substance_Abuse_I #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::17_Full_Opioid_Agonists #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#OME::PreClinical::Neuroscience::Neuroscience_4::Clinical_Cortex::Anesthesia #AK_Step1_v12::#UWorld::COMLEX::24367 #AK_Step2_v12::#AMBOSS::DH01sh #PANCE::BEHAVIORAL::substance_use #AK_Step3_v12::#UWorld::5193 #PANCE::EOR::PSYCH #AK_Step1_v12::#AMBOSS::FOag8k #AK_Step1_v12::#B&B::19_Psych::03_Substance_Use_Disorders::02_Opioids::Extra #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::21_Naloxone #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::13_Medically_supervised_opioid_withdrawal_and_relapse_prevention::03_Naloxone #PANCE::EOR::Family_med #AK_Step1_v12::#UWorld::Step::16052 #AK_Step1_v12::#B&B::01_Anesthesia::01_General::02_Intravenous_Anesthetics::Extra #AK_Step2_v12::#AMBOSS::ZCaZq5 #AK_Step1_v12::#UWorld::COMLEX::26550 #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::04_Opioid_Classification #AK_Step2_v12::#UWorld::Step::12503 #AK_Step2_v12::#SketchyPsych::10_Substance_Use/_Medication_Related_Disorders::01_Substance_Use_Overview